Lv1
40 积分 2024-11-14 加入
Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue
1天前
已完结
Personalised management of alveolar soft part sarcoma: a promising phase 2 study
2天前
已完结
Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself
5天前
已完结
Anlotinib versus placebo as adjuvant therapy for localized high-grade soft tissue sarcomas: a phase 2, double-blinded, randomized controlled trial
9天前
已完结
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
15天前
已完结
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma
19天前
已完结
Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis
24天前
已完结
MCL-153 Ibrutinib Therapy in Relapsed/Refractory Primary Central Nervous System Lymphomas
29天前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
29天前
已完结
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study
1个月前
已完结
皖公网安备34019202002308
